Drug Trial Radar · NCT00570739
Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.
Last checked: Nov 19, 2026Latest source record: Jul 27, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
502
Actual
Start
Nov 2007
Primary completion
Apr 2009
Study completion May 2009
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Dec 11, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 16-week double-blind, placebo-controlled (for colesevelam hydrochloride (HCl)) study in the type 2 diabetic subjects and pre-diabetic subjects. Diabetic participants will also be treated with open label, background,metformin HCl. Two-hundred sixty subjects with type 2 diabetes (T2DM) and 200 pre-diabetic subjects are planned to be be enrolled. Qualified subjects with T2DM will be randomized 1:1 to receive metformin HCl plus colesevelam HCl or metformin HCl plus placebo matching colesevelam HCl. Qualified pre-diabetic subjects will be randomized 1:1 to receive colesevelam HCl or matching placebo.
Conditions
- Type 2 Diabetes Mellitus
- Hypercholesterolemia
- Pre-diabetes
Interventions
Metformin HCl and Colesevelam PlaceboDrug
One or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg placebo tablets once daily for 16 weeks
Metformin HCl tablets and Colesevelam tabletsDrug
One or two Metformin HCl tablets 850 mg (depending on tolerability) and 6 colesevelam 625 mg tablets once daily for 16 weeks
Colesevelam placeboDrug
Six colesevelam 625 mg placebo tablets will be given once a day for 16 weeks
ColesevelamDrug
Six colesevelam 625 mg tablets will be given once a day for 16 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change of Hemoglobin A1C (HbA1C) From Baseline to 16 Weeks When Given as Initial Therapy to Drug-naïve, Diabetic Subjects.Time frame: Baseline to 16 weeks
- Percent Change in Low Density Lipoprotein-Cholesterol (LDL-C) in Pre-Diabetic Subjects From Baseline to 16 WeeksTime frame: Baseline to 16 Weeks
Locations
31 sites in 4 countries. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Los Gatos, California
Site not named
Tarzana, California
Site not named
Ocala, Florida
Site not named
Pocatello, Idaho
Site not named
Gary, Indiana
Site not named
New Orleans, Louisiana
Site not named
Olive Branch, Mississippi
Site not named
Dundee, New York
Site not named
West Seneca, New York
Site not named
Statesville, North Carolina
Site not named
Kent, Ohio
Site not named
Marion, Ohio
Site not named
Portland, Oregon
Site not named
Corpus Christi, Texas
Site not named
Dallas, Texas
Site not named
San Antonio, Texas
Site not named
Barranquilla, Atlántico, Colombia
Site not named
Bogota, Cundinamarca, Colombia
Site not named
Bucaramanga, Santander Department, Colombia
Site not named
Mumbai, Dadar, India
Site not named
Durgāpura, Jaipur, India
Site not named
Bangalore, Karnataka, India
Site not named
Kochi, Kerala, India
Site not named
Nashik, Maharashtra, India
Site not named
Las Palmas, Chihuahua, Mexico
Site not named
Delegacion, Cuauhtemoc, Mexico
Site not named
Guadalajara, Jalisco, Mexico
Site not named
Monterrey, Nuevo León, Mexico
Site not named
Hermosillo, Sonora, Mexico
Site not named
Mérida, Yucatán, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.